• Login
    View Item 
    •   Home
    • Articles and other publications by RIVM employees
    • Miscellaneous
    • View Item
    •   Home
    • Articles and other publications by RIVM employees
    • Miscellaneous
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of WARPCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsPublisherDepartmentThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsPublisherDepartment

    My Account

    LoginRegister

    Statistics

    Display statistics

    Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Publisher version
    View Source
    Access full-text PDFOpen Access
    View Source
    Check access options
    Check access options
    Thumbnail
    Name:
    kimman.pdf
    Size:
    164.4Kb
    Format:
    PDF
    Download
    Average rating
     
       votes
    Cast your vote
    You can rate an item by clicking the amount of stars they wish to award to this item. When enough users have cast their vote on this item, the average rating will also be shown.
    Star rating
     
    Your vote was cast
    Thank you for your feedback
    Authors
    Kimman, Tjeerd G
    Boot, Hein J
    Berbers, Guy A M
    Vermeer-de Bondt, Patricia E
    Wit, G Ardine de
    Melker, Hester E de
    Type
    Article
    Language
    en
    
    Metadata
    Show full item record
    Title
    Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs.
    Publiekssamenvatting
    Among all public health provisions national immunization programs (NIPs) are beyond doubt one of the most effective in reducing mortality, morbidity, and costs associated with major infectious diseases. To maintain their success, NIPs have to modernize in response to many new and old demands regarding efficacy, safety, availability of new vaccines, emerging and evolving pathogens, waning immunity, altered epidemiological situations, and the public's trust in the program. In this paper we present an evaluation model in the form of a checklist that may help in collecting relevant scientific information that is necessary for evaluation and decision making when considering changes in a NIP. Such a checklist points to relevant information on the vaccine-preventable disease, the pathogen causing it, the vaccine, and the cost-effectiveness ratio of the vaccine. However, the final judgment on a potential change in the NIP cannot be based on a simple algorithm, as the relevant information reflects factors of a very different kind and magnitude, to which different value judgements may be added, and which may have certain degrees of uncertainty. Because any change in the NIP may be accompanied by more or less unforeseen changes in the vaccine's efficacy, evolutionary consequences, including the antigenic composition of the pathogen, and the vaccine's safety profile, an intensive surveillance program should accompany any NIP. Elements thereof include clinical-epidemiological surveillance, surveillance of vaccination coverage, immune surveillance, surveillance of microbial population dynamics, and surveillance of adverse events and safety issues. We emphasize that the decision to introduce a vaccine in the NIP should be taken as seriously, both scientifically and ethically, as the decision to withhold a vaccine from the NIP. In the latter case one might be responsible for vaccine-preventable disease and mortality.
    DOI
    10.1016/j.vaccine.2006.03.022
    PMID
    16616803
    URI
    http://hdl.handle.net/10029/6271
    ae974a485f413a2113503eed53cd6c53
    10.1016/j.vaccine.2006.03.022
    Scopus Count
    Collections
    Miscellaneous

    entitlement

    Related articles

    • Decision support in vaccination policies.
    • Authors: Piso B, Wild C
    • Issue date: 2009 Oct 9
    • Criteria for inclusion of vaccinations in public programmes.
    • Authors: Houweling H, Verweij M, Ruitenberg EJ, National Immunisation Programme Review Committee of the Health Council of the Netherlands.
    • Issue date: 2010 Apr 9
    • Enhanced decision support for policy makers using a web interface to health-economic models--illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the Netherlands.
    • Authors: Hubben GA, Bos JM, Glynn DM, van der Ende A, van Alphen L, Postma MJ
    • Issue date: 2007 May 4
    • Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
    • Authors: Wisløff T, Abrahamsen TG, Bergsaker MA, Løvoll Ø, Møller P, Pedersen MK, Kristiansen IS
    • Issue date: 2006 Jul 17
    • The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
    • Authors: Newall AT, Scuffham PA, Kelly H, Harsley S, Macintyre CR
    • Issue date: 2008 Apr 16

    DSpace software (copyright © 2002 - 2021)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.